Mixed options sentiment in Novo Nordisk (NVO), with shares down 84c near $52.05. Options volume roughly in line with average with 69k contracts traded and calls leading puts for a put/call ratio of 0.79, compared to a typical level near 0.64. Implied volatility (IV30) dropped 1.46 near 58.03,in the top quartile of the past year, suggesting an expected daily move of $1.90. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Novo Nordisk (NVO) will report earnings before the open on 2025-11-05.Option markets are pricing in a 50% probability of a move greater than 7.33% or $3.82.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk’s New Study on Haemophilia: What Investors Need to Know
- Novo Nordisk’s New Study on Cagrilintide: A Potential Game-Changer in Weight Management
- Novo Nordisk’s New Weight Loss Study: A Potential Game-Changer in Obesity Treatment
- Novo Nordisk’s New Study on Haemophilia A Treatment: What Investors Need to Know
- Novo Nordisk’s New Obesity Drug Study: What Investors Need to Know